CIK 0001737287
- Non-accelerated filer
- Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823562771
- Phone
- +1 650-457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,698
- in 1 filing
Net −$48,698. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Mayo Stephen Director | Grant or award · Stock Option (Right to buy) | +144,400 | 144,400 | ||
| 2025-06-18 | Mayo Stephen Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2024-06-05 | Mayo Stephen Director | Grant or award · Stock Option (Right to buy) | +191,082 | 191,082 | ||
| 2023-08-07 | Mayo Stephen Director | Sale | −10,000 | $4.29 | $43K | 25,328 |
| 2023-06-13 | Mayo Stephen Director | Grant or award · Stock Option (Right to Buy) | +116,120 | 116,120 | ||
| 2022-07-08 | Mayo Stephen Director | Grant or award | +35,328 | 35,328 | ||
| 2022-07-08 | Mayo Stephen Director | Grant or award · Stock Option (Right to Buy) | +54,487 | 54,487 |
Page 1 of 1 · 7 trades